Tilosa SRL
Tilosa reported total assets of 70,195 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Tilosa shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -21 % Total assets -23 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tilosa's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Tilosa's financial analysis
- Solvency83.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tilosa
Tilosa's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0753.952.294
- VAT number
- BE0753952294
- Peppol
- Registered · 0208:0753952294 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Sep 2020
- Registered office
- 9160 Lokeren
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tilosa (SRL) has been based in Lokeren since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,184 € and equity of 58,434 €; its revenue is not published. Its solvency stands at 83.2%, above the median of its sector (44.2%).
Companies similar to Tilosa
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- MGS Pharma Retail sale of pharmaceutical products Stavelot · balance sheet 68,803 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
- Kato VAN Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
Frequently asked questions about Tilosa
What is the revenue of Tilosa?
Tilosa files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tilosa?
In Belgium, the VAT number is the company number prefixed with BE: BE0753952294 for Tilosa, if the company is VAT-registered. Its company number (CBE) is 0753.952.294.
Where is the registered office of Tilosa?
According to the CBE register, the registered office of Tilosa is in 9160 Lokeren.
What is the equity of Tilosa?
At the close of the 2025 financial year, the equity of Tilosa amounts to 58,434 €, a solvency of 83.2% of total assets.
Who manages Tilosa?
The register lists 2 active mandates at Tilosa. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tilosa
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →